Fairfax Financial (FFH.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Fairfax Financial (FFH.TO)

2,326.80

+5.86 (0.25%)

as of Jul 15, 2026, 8:00:00 pm Market Open.

281 watching

Investor Insights

Jul 15, 2026, 12:00 am

This summary was created by AI, based on 23 opinions in the last 12 months.

Fairfax Financial (FFH-T) is viewed as a solid and well-managed company with a good long-term growth outlook, although the sentiment around it currently appears mixed. While some experts highlight its strong earnings and improved underwriting performance, especially in the context of Q4 results, others suggest that the stock lacks momentum and potential catalysts for short-term growth. The valuation appears reasonable, but not particularly cheap, with much of the easy money already made. Multiple experts believe the stock is at a crossroads, with some viewing it as a decent long-term hold while others recommend being cautious and potentially reallocating investment to better opportunities. Overall, FFH-T's performance may hinge significantly on the company's ability to execute on acquisitions and sustain growth in the competitive insurance space.

Consensus

Hold

Valuation

Fair Value

Similar

SLF

COMMENT

Has followed this company for a long time and has owned it in the past. A unique company which makes it hard to value. He would look at price to book. Historically, they have been a disciplined underwriter of insurance which may mean their stated book value is understated. The underwriting business has become very difficult. It is probably still undervalued.

TOP PICK

It is a bet on the investing acumen of the management team. The insurance business is firing on all cylinders. They have strong revenue growth. You are going to see strong growth in book value. They are currently trading at a discount of 30% to book value. (Analysts’ price target is $515.54)

HOLD

It is not a stock he has paid attention to in the past but he is starting to notice it. They invest in distressed value stocks and are contrarian. Now is the time that the sun might start to come out for them. He bought some recently to play the value recovery.

COMMENT

It is a well-run company but it tends to make very big bets. More often than not, they get it right. Right now, we are in a difficult market environment to fundamentally see the right value. Generally, you want to be cautious. Over the long run, they should do well.

DON'T BUY

He prefers buying a insurance company directly like Manulife and Intact. Though well-run, FFH has a mixed bag of many assets. This mix adds a level of risk vs. pure insurers.

COMMENT

Good job growing book value. Multiple contracting, consolidation period. So something to look at. Hasn't done a ton of research on it.

DON'T BUY

It was a counter cyclical until they took all their losses and now have all these junky names that aren't doing that well, so it is pro-cyclical. He would stay away from it.

DON'T BUY

Some of the recent investments have been questionable and the stock has been underperforming for a while. It is probably at a deep discount compared to its book value. He has moved away from conglomerate insurance companies.

DON'T BUY

He thinks they failed on several fronts. Their insurance division faces interest rates that are zero or going negative. If we stay in a deflation world, it will be hell for them for the next several years. He sees no reason to own this right now.

BUY

It has wide swings with respect to its earnings profile. Its insurance operations have been fairly steady. You will see more volatility in the stock short term, yet there has been a lot of management buying of the stock. It is a very well managed company that will continue to do well.

WAIT

FFH buying BB? He thought the rumour of FFH buying BB created a lot of volume, which made him suspect. BB has a lot of automotive exposure, which hold back their recovery post-pandemic. BB has a cyber-security division that may lead to some opportunities.

DON'T BUY

The environment is so difficult for them. They are not making any money on the float. If it drops below $314, the market is questioning the viability of the balance sheet. The tide is going out. Put a stop in place.

DON'T BUY

Prem Watsa has been under fire lately. Their underlying insurance business will struggle under low interest rates to generate profits and income. Watsa's investments in the past decade have been dubious.

PAST TOP PICK

(A Top Pick Feb 05/19, Down 7%) He still likes it. It is a very well run company. Today their insurance business is as strong as it has ever been. They've been doing a good job monetizing some investments on the investment side of the business. It is trading at book but peers are trading at 1.5 times book.

PAST TOP PICK

(A Top Pick Sep 12/19, Up 2%) He still thinks Prem Watsa will deliver. FFH has a global reach and long-term commitment to India. $540-600 band is supportive, but he's looking for upside above $600-620. If so, this could go to $800.

Showing 91 to 105 of 458 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Colin Cieszynski

SIA Wealth Management

Keith Richards

ValueTrend Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Fairfax Financial (FFH.TO)